Search details
1.
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals.
Cell
; 181(7): 1489-1501.e15, 2020 06 25.
Article
in English
| MEDLINE | ID: mdl-32473127
2.
Structure and neutralization mechanism of a human antibody targeting a complex Epitope on Zika virus.
PLoS Pathog
; 19(1): e1010814, 2023 Jan.
Article
in English
| MEDLINE | ID: mdl-36626401
3.
A conserved set of mutations for stabilizing soluble envelope protein dimers from dengue and Zika viruses to advance the development of subunit vaccines.
J Biol Chem
; 298(7): 102079, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35643320
4.
A Novel Antigenic Site Spanning Domains I and III of the Zika Virus Envelope Glycoprotein Is the Target of Strongly Neutralizing Human Monoclonal Antibodies.
J Virol
; 95(9)2021 04 12.
Article
in English
| MEDLINE | ID: mdl-33597214
5.
Dengue type 1 viruses circulating in humans are highly infectious and poorly neutralized by human antibodies.
Proc Natl Acad Sci U S A
; 116(1): 227-232, 2019 01 02.
Article
in English
| MEDLINE | ID: mdl-30518559
6.
Novel Assay to Measure Seroprevalence of Zika Virus in the Philippines.
Emerg Infect Dis
; 27(12): 3073-3081, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34808091
7.
Natural immunogenic properties of bioinformatically predicted linear B-cell epitopes of dengue envelope and pre-membrane proteins.
BMC Immunol
; 22(1): 71, 2021 11 03.
Article
in English
| MEDLINE | ID: mdl-34732126
8.
Dimerization of Dengue Virus E Subunits Impacts Antibody Function and Domain Focus.
J Virol
; 94(18)2020 08 31.
Article
in English
| MEDLINE | ID: mdl-32611757
9.
Seroepidemiology of SARS-CoV-2 infections in an urban population-based cohort in León, Nicaragua.
Epidemiol Infect
; 149: e247, 2021 10 20.
Article
in English
| MEDLINE | ID: mdl-35172912
10.
Severe Dengue Epidemic, Sri Lanka, 2017.
Emerg Infect Dis
; 26(4): 682-691, 2020 04.
Article
in English
| MEDLINE | ID: mdl-32186490
11.
Human dengue virus serotype 2 neutralizing antibodies target two distinct quaternary epitopes.
PLoS Pathog
; 14(2): e1006934, 2018 02.
Article
in English
| MEDLINE | ID: mdl-29481552
12.
Cutting Edge: Transcriptional Profiling Reveals Multifunctional and Cytotoxic Antiviral Responses of Zika Virus-Specific CD8+ T Cells.
J Immunol
; 201(12): 3487-3491, 2018 12 15.
Article
in English
| MEDLINE | ID: mdl-30413672
13.
Beyond Neutralizing Antibody Levels: The Epitope Specificity of Antibodies Induced by National Institutes of Health Monovalent Dengue Virus Vaccines.
J Infect Dis
; 220(2): 219-227, 2019 06 19.
Article
in English
| MEDLINE | ID: mdl-30895307
14.
Physiological temperatures reduce dimerization of dengue and Zika virus recombinant envelope proteins.
J Biol Chem
; 293(23): 8922-8933, 2018 06 08.
Article
in English
| MEDLINE | ID: mdl-29678884
15.
Innovative and New Approaches to Laboratory Diagnosis of Zika and Dengue: A Meeting Report.
J Infect Dis
; 217(7): 1060-1068, 2018 03 13.
Article
in English
| MEDLINE | ID: mdl-29294035
16.
Longitudinal Analysis of Antibody Cross-neutralization Following Zika Virus and Dengue Virus Infection in Asia and the Americas.
J Infect Dis
; 218(4): 536-545, 2018 07 13.
Article
in English
| MEDLINE | ID: mdl-29618091
17.
Analyzing the Human Serum Antibody Responses to a Live Attenuated Tetravalent Dengue Vaccine Candidate.
J Infect Dis
; 217(12): 1932-1941, 2018 05 25.
Article
in English
| MEDLINE | ID: mdl-29800370
18.
Development of Envelope Protein Antigens To Serologically Differentiate Zika Virus Infection from Dengue Virus Infection.
J Clin Microbiol
; 56(3)2018 03.
Article
in English
| MEDLINE | ID: mdl-29263206
19.
Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to Dengue Virus Serotype 4 Infection and Vaccination.
J Virol
; 91(5)2017 03 01.
Article
in English
| MEDLINE | ID: mdl-28031369
20.
Prior Dengue Virus Exposure Shapes T Cell Immunity to Zika Virus in Humans.
J Virol
; 91(24)2017 12 15.
Article
in English
| MEDLINE | ID: mdl-28978707